NONINFECTIOUS MYELITIS

This adverse event was reported 82 times

These drugs are most commonly taken by patients reporting NONINFECTIOUS MYELITIS:

# Drug Count
0 DIMETHYL FUMARATE 18
1 INTERFERON BETA-1A 11
2 NATALIZUMAB 8
3 CYTARABINE 6
4 OCRELIZUMAB 6
5 PEGINTERFERON BETA-1A 6
6 PREGABALIN 6
7 RITUXIMAB-ABBS 6
8 CARBOPLATIN 5
9 DALFAMPRIDINE 4
See all common drugs associated with NONINFECTIOUS MYELITIS

NONINFECTIOUS MYELITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOFERSEN 3 0.0053
1 RITUXIMAB-ABBS 6 0.0012
2 DARIFENACIN HYDROBROMIDE 1 0.0012
3 PEGINTERFERON BETA-1A 6 0.0005
4 RILUZOLE 1 0.0004
5 CALCIFEDIOL 1 0.0004
6 NUSINERSEN 2 0.0003
7 NORTRIPTYLINE HYDROCHLORIDE 1 0.0002
8 DIROXIMEL FUMARATE 2 0.0002
9 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 1 0.0001
See all drugs enriched for association with NONINFECTIOUS MYELITIS

NONINFECTIOUS MYELITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Benzothiazole [EPC] 1 0.0004
1 Antisense Oligonucleotide [EPC] 5 0.0004
2 Sigma-1 Agonist [EPC] 1 0.0001
3 Antimalarial [EPC] 1 0.0001
4 Antiprotozoal [EPC] 1 0.0001
5 Integrin Receptor Antagonist [EPC] 8 0.0001
6 Interferon beta [EPC] 17 0.0001
7 Provitamin D2 Compound [EPC] 2 0.0001
8 Potassium Channel Blocker [EPC] 4 0.0001
9 CD20-directed Cytolytic Antibody [EPC] 13 0.0000
See all drug classes enriched for association with NONINFECTIOUS MYELITIS